Information  X 
Enter a valid email address

B.P. Marsh &Partners (BPM)


Tuesday 23 June, 2020

B.P. Marsh &Partners

Total Voting Rights

RNS Number : 8195Q
B.P. Marsh & Partners PLC
23 June 2020

Date:     23 June 2020

On behalf of:  B.P. Marsh & Partners Plc

Immediate release

B.P. Marsh & Partners Plc

("B.P. Marsh" or the "Company")

Changes in Voting Rights


B.P. Marsh, the specialist investor in early stage financial services businesses, announces that on 18th June 2020, a total of 25,110 ordinary shares of 10p each ("Ordinary Shares") which were being held in treasury were transferred to the B.P. Marsh SIP Trust.


At the date of this announcement, the total number of Ordinary Shares in issue is 37,466,000, and the total number of current voting rights in B.P. Marsh, is 37,423,138. The Company holds 42,862 Ordinary Shares in Treasury. The figure of 37,423,138 may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.


For further information:


B.P. Marsh & Partners Plc

Brian Marsh OBE    +44 (0)20 7233 3112


Nominated Adviser & Broker

Panmure Gordon

Atholl Tweedie / Charles Leigh-Pemberton / Ailsa MacMaster  +44 (0)20 7886 2500


The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.



Notes to Editors:

B.P. Marsh's current portfolio contains seventeen companies. More detailed descriptions of the portfolio can be found at

Since formation over 25 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for approaching ten years. 

- Ends - 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t